Clinical Trial Update: Study of OT202 in Treating Moderate to Severe Dry Eye [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating OT202 for moderate to severe dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OT202

Snippet

Sponsor: Ocumension Therapeutics (Shanghai) Co., Ltd | Conditions: Dry Eye | Phase 2 | Status: COMPLETED